TCV Trust & Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.54M | Sell |
10,111
-162
| -2% | -$34.9K | 0.19% | 75 |
|
|
2026
Q1 | $2.23M | Sell |
10,273
-3,029
| -23% | -$672K | 0.19% | 74 |
|
|
2025
Q4 | $3.04M | Buy |
13,302
+60
| +0.5% | +$13.7K | 0.25% | 70 |
|
|
2025
Q3 | $3.07M | Buy |
13,242
+1,013
| +8% | +$206K | 0.26% | 69 |
|
|
2025
Q2 | $2.27M | Buy |
12,229
+161
| +1% | +$29.9K | 0.2% | 74 |
|
|
2025
Q1 | $2.53M | Buy |
12,068
+2,839
| +31% | +$552K | 0.23% | 73 |
|
|
2024
Q4 | $1.64M | Sell |
9,229
-867
| -9% | -$159K | 0.15% | 80 |
|
|
2024
Q3 | $1.99M | Sell |
10,096
-281
| -3% | -$52.4K | 0.18% | 76 |
|
|
2024
Q2 | $1.78M | Sell |
10,377
-30
| -0.3% | -$4.97K | 0.17% | 78 |
|
|
2024
Q1 | $1.9M | Sell |
10,407
-215
| -2% | -$37.1K | 0.18% | 79 |
|
|
2023
Q4 | $1.65M | Buy |
10,622
+380
| +4% | +$55.4K | 0.17% | 79 |
|
|
2023
Q3 | $1.53M | Buy |
10,242
+295
| +3% | +$43.3K | 0.17% | 81 |
|
|
2023
Q2 | $1.34M | Sell |
9,947
-757
| -7% | -$111K | 0.14% | 89 |
|
|
2023
Q1 | $1.71M | Buy |
10,704
+866
| +9% | +$132K | 0.19% | 80 |
|
|
2022
Q4 | $1.59M | Sell |
9,838
-18
| -0.2% | -$2.76K | 0.18% | 83 |
|
|
2022
Q3 | $1.32M | Sell |
9,856
-56
| -0.6% | -$8.04K | 0.17% | 85 |
|
|
2022
Q2 | $1.52M | Buy |
9,912
+55
| +0.6% | +$8.4K | 0.18% | 85 |
|
|
2022
Q1 | $1.6M | Buy |
9,857
+180
| +2% | +$26.1K | 0.17% | 89 |
|
|
2021
Q4 | $1.31M | Sell |
9,677
-288
| -3% | -$34K | 0.13% | 101 |
|
|
2021
Q3 | $1.07M | Buy |
9,965
+382
| +4% | +$43.6K | 0.12% | 106 |
|
|
2021
Q2 | $1.08M | Buy |
9,583
+100
| +1% | +$11.3K | 0.12% | 103 |
|
|
2021
Q1 | $1.03M | Sell |
9,483
-494
| -5% | -$52.8K | 0.12% | 102 |
|
|
2020
Q4 | $1.07M | Sell |
9,977
-675
| -6% | -$64.9K | 0.13% | 101 |
|
|
2020
Q3 | $933K | Buy |
10,652
+920
| +9% | +$86.6K | 0.13% | 99 |
|
|
2020
Q2 | $956K | Sell |
9,732
-82
| -0.8% | -$7.22K | 0.14% | 94 |
|
|
2020
Q1 | $748K | Sell |
9,814
-609
| -6% | -$51.9K | 0.12% | 94 |
|
|
2019
Q4 | $923K | Buy |
10,423
+369
| +4% | +$30.6K | 0.11% | 100 |
|
|
2019
Q3 | $762K | Sell |
10,054
-100
| -1% | -$6.86K | 0.1% | 107 |
|
|
2019
Q2 | $738K | Sell |
10,154
-2,740
| -21% | -$215K | 0.1% | 110 |
|
|
2019
Q1 | $1.04M | Sell |
12,894
-2,595
| -17% | -$212K | 0.14% | 94 |
|
|
2018
Q4 | $1.43M | Sell |
15,489
-4,205
| -21% | -$370K | 0.21% | 85 |
|
|
2018
Q3 | $1.86M | Buy |
19,694
+150
| +0.8% | +$14.2K | 0.25% | 83 |
|
|
2018
Q2 | $1.81M | Sell |
19,544
-1,318
| -6% | -$129K | 0.25% | 82 |
|
|
2018
Q1 | $1.97M | Buy |
20,862
+425
| +2% | +$46.7K | 0.28% | 76 |
|
|
2017
Q4 | $1.98M | Sell |
20,437
-400
| -2% | -$37.7K | 0.28% | 79 |
|
|
2017
Q3 | $1.85M | Sell |
20,837
-25
| -0.1% | -$1.9K | 0.27% | 77 |
|
|
2017
Q2 | $1.51M | Sell |
20,862
-885
| -4% | -$59.5K | 0.23% | 84 |
|
|
2017
Q1 | $1.42M | Buy |
21,747
+4,651
| +27% | +$292K | 0.22% | 86 |
|
|
2016
Q4 | $1.07M | Hold |
17,096
| – | – | 0.17% | 97 |
|
|
2016
Q3 | $1.08M | Sell |
17,096
-1,050
| -6% | -$68K | 0.18% | 89 |
|
|
2016
Q2 | $1.12M | Sell |
18,146
-250
| -1% | -$15.2K | 0.2% | 90 |
|
|
2016
Q1 | $1.05M | Sell |
18,396
-565
| -3% | -$31.5K | 0.19% | 90 |
|
|
2015
Q4 | $1.12M | Hold |
18,961
| – | – | 0.2% | 88 |
|
|
2015
Q3 | $1.03M | Hold |
18,961
| – | – | 0.19% | 94 |
|
|
2015
Q2 | $1.27M | Hold |
18,961
| – | – | 0.21% | 91 |
|
|
2015
Q1 | $1.11M | Hold |
18,961
| – | – | 0.18% | 95 |
|
|
2014
Q4 | $1.24M | Sell |
18,961
-1,845
| -9% | -$116K | 0.2% | 93 |
|
|
2014
Q3 | $1.2M | Sell |
20,806
-870
| -4% | -$48.3K | 0.2% | 95 |
|
|
2014
Q2 | $1.22M | Buy |
21,676
+180
| +0.8% | +$9.44K | 0.2% | 94 |
|
|
2014
Q1 | $1.1M | Sell |
21,496
-2,075
| -9% | -$105K | 0.19% | 97 |
|
|
2013
Q4 | $1.25M | Sell |
23,571
-409
| -2% | -$20.1K | 0.21% | 98 |
|
|
2013
Q3 | $1.07M | Sell |
23,980
-7,784
| -25% | -$345K | 0.21% | 94 |
|
|
2013
Q2 | $1.31M | Buy |
+31,764
| New | +$1.39M | 0.27% | 86 |
|
Other funds holding ABBV
ECSS
ATO
TCV Trust & Wealth Management's ABBV Position: Q2 2026 in Review
TCV Trust & Wealth Management reduced its AbbVie (ABBV) stake by 1.6% in Q2 2026, selling an estimated $34.9K and leaving 10,111 shares worth $2.54M. The position accounts for 0.19% of the portfolio, ranked #75.
TCV Trust & Wealth Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.07M in Q3 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- TCV Trust & Wealth Management held 10,111 shares of AbbVie worth $2.54M as of Q2 2026.
- TCV Trust & Wealth Management sold 162 AbbVie shares in Q2 2026, an estimated $34.9K.
- AbbVie made up 0.19% of TCV Trust & Wealth Management's portfolio in Q2 2026, its #75 holding.
- TCV Trust & Wealth Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- TCV Trust & Wealth Management's AbbVie position peaked at $3.07M in Q3 2025.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on TCV Trust & Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.